David van Duin

Infections After Kidney Transplantation From Donors With Human Immunodeficiency Virus (HIV) to Recipients With HIV Among 198 kidney transplant recipients with HIV, the rate and spectrum of posttransplant infections were similar regardless of donor HIV status. HIV donor-

Kidney transplantation (KT) from donors with HIV to recipients with HIV is noninferior to KT from donors without HIV in terms of safety. In CID, authors describe the burden and timeline of post-KT infections and assess associations with HIV donor status. https://bit.ly/4jNGe8D

Dr. Lauren Collins Memorial Fund This fund was created by Dr. Collins' family in her honor. The fund is dedicated to continue efforts at the Grady Ponce De Leon Center to end the HIV Epidemic through person-centered, interprofessiona...

We lost a beloved a beloved ID colleague & friend unexpectedly this week. Dr. Lauren Collins' legacy and the many lives she touched will live on. A compassionate physician who was leader in the fight to end HIV locally and nationally.
#IDSky
gradyhealthfoundation.donorsupport.co/page/laurenc...

Evidence for antibiotic durations in chronic bacterial prostatitis: A systematic review Optimal antibiotic durations for chronic bacterial prostatitis (CBP) are unknown; current guidelines recommend 4–12 weeks.To systematically review the…

📣 Systematic review by @lcordes.bsky.social, @bwtrautner.bsky.social, @merellambregts.bsky.social et al assessing evidence for long #antibiotic durations in chronic bacterial #prostatitis. Spoiler: there isn’t much.

#IDSky #clinmicro #UroSky #MedSky #OA #AMR

www.sciencedirect.com/science/arti...

📚We launched ESCMID Media last year, where our members can watch everything from past webinars to sessions from #ESCMIDGlobal and other conferences!

👀Explore it now: https://media.escmid.org/

#IDSky #clinmicro

How do microbiomes drive—and solve—AMR? 🧫

Join IMARI 26 pre-meeting workshop “Microbiomes as Reservoirs, Catalysts, and Solutions for AMR” with Dr. Amy Mathers & Dr. Romney Humphries to learn more.

Add it when you register ➡️ https://imari.org/registration/

YouTube video by ISAC / APUA WAAW 2025 | Federation of Infectious Diseases Societies of Southern Africa (FIDSSA)

🌍 For #WAAW2025, ISAC invited Member Societies to share efforts against #AMR

Dr Dena van den Bergh explains a study by South African Antibiotic Stewardship Programme that aims to empower the next generation of leaders to implement AMS at scale
Watch now: youtu.be/p2Jsaq3jhIE
@souhakanj.bsky.social

Communicable E40: AMR in conflict and crisis zones It’s World AMR Awareness Week (WAAW) and we have prepared a special...

🎙️ Just published: Communicable E40: AMR in conflict and crisis zones

Hosted by Nav Narayanan & Thomas Tängdén

w/ invited guests Aula Abbara (UK), Guido Granata (Italy), Tuomas Aro (Finland)

Listen on #Communicable:

#IDSky #Clinmicro #WAAW2025 #AMR @taescmid.bsky.social

Clinical and genomic characterization of Serratia bloodstream infections Previously considered a rare opportunistic pathogen, Serratia is now an emerging cause of bacteraemia. We compared the risk factors and outcomes of patients with Serratia bacteraemia relative to other...

📣 In a US cohort of >2500 #bacteremia patients, #Serratia marcescens was associated with persistent bacteremia and cardiac devices. Yet WGS showed genetic diversity of isolates: infections are not clonal.

#IDSky #clinmicro #MedSky @vancefowler.bsky.social

www.cmi-comms.org/article/S295...

Gave my 1st talk in NL: how to make multicenter data analysis with patient data actually work.

tl;dr: common data models (global interoperability) + LLMs (data harmonization, mapping, future-proofing) + federated learning (privacy)

Let me know what you think!

drive.google.com/file/d/1N3yk...

Looking forward to UNC Institute of Global Health and Infectious Diseases Friday talk globalhealth.unc.edu/education/fr...

🎯

Peri–Covid-19 antibiotic use was associated with downstream antimicrobial resistance, and particularly the presence of gram-negative antibiotic-resistant organisms @nejm.org
evidence.nejm.org/doi/full/10....

Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:

See next posts

Getting ready for #IDBugBowl @idweek.bsky.social Hope to see y’alll this afternoon. Come and cheer ur team UAB CCF ThomasJefferson and our international team Calcutta Troo Med #IDWeek2025 #IDSky

Dr Cesar Arias delivers Maxwell Finland Lecture #IDweek2025
“Antimicrobials save the patient and reduce infectiousness”
“My research comes from a question in one patient”

💯

Dr Yohei Doi now introducing Dr. Cesar Arias as the Maxwell Finland lecturer. #IDWeek2025

A pioneer in AMR research 🤩

Infectious Diseases Society of America Infectious Diseases Society of America

As #IDWeek2025 begins, thousands of ID experts are uniting to defend science and public health. Urge Congress to fully fund ID research, preparedness and care, and hold the Administration accountable.

Your voice matters. Take action: https://idsociety.quorum.us/campaign/144678/

Dr Tamma: Susceptibility for cefuroxime, cefoodoxime, cefdinir, cefixime looking encouraging in ceftriaxone-susceptible Enterobacterales from BSI at Hopkins.
#IDweek2025 #IDsky

pubmed.ncbi.nlm.nih.gov/39745384/

Dr Tamma mentions the ongoing GOAT trial (PI Tamma & Cosgrove)
This will be a most needed and important study. clinicaltrials.gov/study/NCT060...
#IDweek2025 #IDsky

Dr Tamma now discusses the interpretation of ceftriaxone susceptibility testing for the use of oral cephalosporins.
#IDweek2025 #IDsky

Most people in observational studies of GN BSI were transitioned to oral late, and mostly to FQ or tmp/smx

Don’t miss @bwtrautner.bsky.social and I talk about what’s new in UTI (the UTI WikiGuideline and IDSA cUTI guideline) on Wednesday AM at 08:00 EST! #idweek2025 #idsky

Welcome to Atlanta #IDWeek2025! Check out this great guide to our city from the #EmoryID fellows! The Eastside Beltline is my fave

Dr Molina now discusses the important ARLG study DOTS.
Primary outcome was a desirability of outcome ranking analysis
Similar in dalba vs SOC
#idweek2025 #idsky

Curious about new antibacterials in the pipeline? Check out Monday 8am session in B302 and be (among) the first to know.
#IDweek2025 #IDsky

Dr. Molina now summarizing data on the use of long-acting anti-gram-positive bacterial agents: dalbavancin, and oritavancin
#IDweek2025 #IDsky

Nice summary by Dr. Nguyen on the use of oral B-lactams. Concerns over cefdinir bio availability. Overall limited but encouraging data for use in streptococcal infections. Probably too soon for MSSA.
#IDWeek2025 #IDsky

Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.

Don’t throw away your shot to watch the #IDWeek2025 Opening Plenary live! Tune in at 3:45PM ET to see Javier Muñoz and other special guests kick off the meeting: https://idweek2025.eventscribe.net/aaStatic.asp?SFP=WldXSkRZU0dAMjQyMjY

#IDWeek2025 let’s go!
#IDsky

This is an awesome opportunity @escmid.bsky.social @taescmid.bsky.social @idsainfo.bsky.social